About Alector (ALEC)
Alector, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration. Immuno-neurology targets immune dysfunction as a cause of multiple pathologi... Read more
- USD5.19
- USD5.32
- USD5.06
- USD9.07
- -12.60%
- 97M
- 607.60k
- 506M
- 3.66
- -20.30%
Stock News
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
